Long-term survivor of gastric small cell carcinoma.
We describe the long-term survival of a patient following the diagnosis of primary gastric small cell carcinoma. In January 2000, a 73-year-old male was found to have advanced gastric small cell carcinoma directly invading his liver. He received combination chemotherapy with cisplatin and irinotecan as first-line chemotherapy, then cisplatin and etoposide as second-line chemotherapy. He had a complete response after four cycles of second-line chemotherapy. In March 2001, the tumor recurred in the stomach and the patient underwent a total gastrectomy. He has survived free of disease for more than 2 years after the first diagnosis.
Hosokawa
Ayumu
A
Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
Shimada
Yasuhiro
Y
Shirao
Kuniaki
K
Matsumura
Yasuhiro
Y
Yamada
Yasuhide
Y
Muro
Kei
K
Hamaguchi
Tetsuya
T
Gotoh
Masahiro
M
Shimoda
Tadakazu
T
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D005743:Gastrectomy; D005753:Gastric Mucosa / Q000473:pathology; D005773:Gastroscopy; D006801:Humans; D008297:Male; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D017741:Survivors; D014057:Tomography, X-Ray Computed; D002578:Uterine Cervical Dysplasia